Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023 at 13:59 PM EDT
MediLink Therapeutics out-licensed global rights for its antibody-drug conjugate candidate to BioNTech in a $1.1 billion agreement. Meanwhile, BioMap formed a collaboration with Sanofi in a deal with potential value of more than $1 billion.
